A Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis B
Clinical trial NCT03038113 · COMPLETED
Trial details
- NCT number
- NCT03038113
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-06
- Primary completion
- 2019-10-18
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.